(Q80381205)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15275097%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Sterol biosynthesis inhibitors: potential chemotherapeutics against Chagas disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15275097%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

1 reference

R Docampo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15275097%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

G A Schmuñis

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15275097%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 April 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15275097%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15275097%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15275097%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15275097%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

129-130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15275097%20AND%20SRC:MED&resulttype=core&format=json

Interruption of Chagas' disease transmission through vector elimination.

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

Present status of chemotheraphy and chemoprophylaxis of human trypanosomiasis in the Western Hemisphere

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

Anti-Trypanosoma cruzi agglutinins in acute human Chagas' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

[Treatment of the undetermined form of Chagas disease with nifortimox and benzonidazole]

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

Cure of short- and long-term experimental Chagas' disease using D0870

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

The sterols of Trypanosoma cruzi and Crithidia fasciculata

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

Biochemical and ultrastructural alterations produced by miconazole and econazole in Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

Ketoconazole Inhibition of Intracellular Multiplication of Trypanosoma cruzi and Protection of Mice Against Lethal Infection with the Organism

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

Ketoconazole and other potent antimycotic azoles exhibit pronounced activity against Trypanosoma cruzi, Plasmodium berghei and Entamoeba histolytica in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

Effects of ketoconazole on sterol biosynthesis by Trypanosoma cruzi epimastigotes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

The activity of ketoconazole and other azoles against Trypanosoma cruzi: biochemistry and chemotherapeutic action in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

In vitro and in vivo effects of itraconazole against Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

Alteration of lipid order profile and permeability of plasma membranes from Trypanosoma cruzi epimastigotes grown in the presence of ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

Antiproliferative synergism of the allylamine SF 86-327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

Failure of ketoconazole to cure chronic murine Chagas' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

An experimental and clinical assay with ketoconazole in the treatment of Chagas disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

Antiproliferative effects of delta 24(25) sterol methyl transferase inhibitors on Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

Activity of ICI 195,739--a novel, orally active bistriazole--in rodent models of fungal and protozoal infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

Antiproliferative effects and mechanism of action of ICI 195,739, a novel bis-triazole derivative, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

Ultrastructural alterations induced by ICI 195,739, a bis-triazole derivative with strong antiproliferative action against Trypanosoma (Schizotrypanum) cruzi

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901021-1

7 January 2021

10.1016/S0169-4758(97)01021-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15275097%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference